Paul Brennan
Reader
Medicine
Cardiff University School of Medicine
United Kingdom
Biography
Career overview 2012 - present: Reader, Cancer & Genetics, School of Medicine, Cardiff University 2003-2012: Senior Lecturer, Infection & Immunity, School of Medicine, Cardiff University 1999-2003: Lecturer, Infection and Immunity, University of Wales College of Medicine 1995-1999 Research Fellow, Lymphocyte Activation Lab, Imperial Cancer Research Fund, London, UK Education and qualifications 2013: Fellow of Higher Education Academy 1995: Ph.D. Biochemistry Department, Trinity College, Dublin 2, Ireland 1991: B.A. (Mod.) (1st Class) Biochemistry Department, Trinity College, Dublin Professional memberships Member of the Biochemical Society Member of the British Society for Immunology Committees and reviewing Deputy Chair of Athena SWAN School of Medicine Self Assessment Team Member of Cardiff University Genetic Modification and Biological Agents Safety Committee Member of Cardiff Univesity Athena SWAN Self Assessment Team
Research Interest
I am a Reader in the Division of Cancer & Genetics at the School of Medicine I am a key member of the Cardiff CLL Research Group which studies chronic lymphocytic leukaemia. We benefit from funding from Bloodwise and the Leukaemia Research Appeal for Wales. I am the Director of Post-Doctoral Studies and Chair of the Post-doctoral Development Committee at the School of Medicine I am deputy chair of the Athena SWAN Self Assessment Team for the School of Medicine.
Publications
-
Walsby, E.et al. 2014. Development and characterization of a physiologically relevant model of lymphocyte migration in chronic lymphocytic leukemia. Blood 123(23), pp. 3607-3617. (10.1182/blood-2013-12-544569)
-
Welton, J.et al. 2016. Proteomics analysis of vesicles isolated from plasma and urine of prostate cancer patients using a multiplex, aptamer-based protein array. Journal of Extracellular Vesicles 5, article number: 31209. (10.3402/jev.v5.31209)
-
Alsagaby, S. A., Brennan, P. and Pepper, C. 2016. Key molecular drivers of chronic lymphocytic leukemia. Clinical Lymphoma, Myeloma and Leukemia 16(11), pp. 593-606. (10.1016/j.clml.2016.08.008)